283 related articles for article (PubMed ID: 23783552)
61. Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3.
Shi H; Liu H; Zhao G
Mol Biol Rep; 2012 Oct; 39(10):9299-306. PubMed ID: 22760257
[TBL] [Abstract][Full Text] [Related]
62. Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application.
Ren G; Li G
Int J Biol Macromol; 2021 Jul; 182():264-275. PubMed ID: 33836193
[TBL] [Abstract][Full Text] [Related]
63. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells.
Shih YP; Takada Y; Lo SH
Mol Cancer Res; 2012 Jan; 10(1):34-9. PubMed ID: 22064653
[TBL] [Abstract][Full Text] [Related]
64. Cooperation of DLC1 and CDK6 affects breast cancer clinical outcome.
Dai X; Li L; Liu X; Hu W; Yang Y; Bai Z
G3 (Bethesda); 2014 Nov; 5(1):81-91. PubMed ID: 25425654
[TBL] [Abstract][Full Text] [Related]
65. Epigenetic regulation of putative tumor suppressor TGFBI in human leukemias.
Fang H; Liu J; Guo D; Liu P; Zhao Y
Chin Med J (Engl); 2014; 127(9):1645-50. PubMed ID: 24791868
[TBL] [Abstract][Full Text] [Related]
66. Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
Li X; Wu X; Li Y; Cui Y; Tian R; Singh N; Ding M; Yang Y; Gao Y
Oncol Rep; 2019 Apr; 41(4):2351-2360. PubMed ID: 30720133
[TBL] [Abstract][Full Text] [Related]
67. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.
Davudian S; Shajari N; Kazemi T; Mansoori B; Salehi S; Mohammadi A; Shanehbandi D; Shahgoli VK; Asadi M; Baradaran B
Biomed Pharmacother; 2016 Dec; 84():191-198. PubMed ID: 27657827
[TBL] [Abstract][Full Text] [Related]
68. DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
Wang D; Qian X; Rajaram M; Durkin ME; Lowy DR
Oncotarget; 2016 Jul; 7(29):45144-45157. PubMed ID: 27174913
[TBL] [Abstract][Full Text] [Related]
69. Reduced expression of RAS protein activator like-1 in gastric cancer.
Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M
Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946
[TBL] [Abstract][Full Text] [Related]
70. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
Chen M; Zhang J; Li N; Qian Z; Zhu M; Li Q; Zheng J; Wang X; Shi G
PLoS One; 2011; 6(10):e25564. PubMed ID: 22039417
[TBL] [Abstract][Full Text] [Related]
71. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.
Mori Y; Cai K; Cheng Y; Wang S; Paun B; Hamilton JP; Jin Z; Sato F; Berki AT; Kan T; Ito T; Mantzur C; Abraham JM; Meltzer SJ
Gastroenterology; 2006 Sep; 131(3):797-808. PubMed ID: 16952549
[TBL] [Abstract][Full Text] [Related]
72. GAP-independent functions of DLC1 in metastasis.
Barras D; Widmann C
Cancer Metastasis Rev; 2014 Mar; 33(1):87-100. PubMed ID: 24338004
[TBL] [Abstract][Full Text] [Related]
73. Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease.
Kang Z; Xu F; Zhang QA; Lin J; Wu Z; Zhang X; Luo Y; Xu J; Guan M
Mod Pathol; 2012 Aug; 25(8):1160-8. PubMed ID: 22522847
[TBL] [Abstract][Full Text] [Related]
74. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
[TBL] [Abstract][Full Text] [Related]
75. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
[TBL] [Abstract][Full Text] [Related]
76. Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter.
Iwamoto S; Withers DA; Handa K; Hakomori S
Glycoconj J; 1999 Oct; 16(10):659-66. PubMed ID: 10972144
[TBL] [Abstract][Full Text] [Related]
77. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
[TBL] [Abstract][Full Text] [Related]
78. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
Tripathi V; Popescu NC; Zimonjic DB
Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
[TBL] [Abstract][Full Text] [Related]
79. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.
Zhou X; Yang XY; Popescu NC
Biochem Biophys Res Commun; 2012 Apr; 420(2):325-30. PubMed ID: 22425986
[TBL] [Abstract][Full Text] [Related]
80. Considerations when analyzing the methylation status of PTEN tumor suppressor gene.
Zysman MA; Chapman WB; Bapat B
Am J Pathol; 2002 Mar; 160(3):795-800. PubMed ID: 11891178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]